Latest Breaking News On - Infrapopliteal artery disease - Page 1 : comparemela.com

Drug-eluting scaffold superior to angioplasty for infrapopliteal artery disease

1. In this randomized controlled trial, for patients with chronic limb-threatening ischemia (CLTI) due to infrapopliteal artery disease (IAD), a drug-eluting resorbable scaffold was superior to angioplasty in reducing the risk of vascular events. 2. There was no significant difference in the adverse events between the drug-eluting resorbable scaffold and angioplasty groups. Evidence Rating Level:

Minute medicine incRating levelConfidence intervalAngioplastyCardiologyChronic diseaseDrug eluting scaffoldEverolimusInfrapopliteal artery diseaseLimb threatening ischemiaSurgeryVascular surgery

Everolimus-eluting scaffold found better than angioplasty for CLTI patients with infrapopliteal artery disease

Everolimus-eluting scaffold found better than angioplasty for CLTI patients with infrapopliteal artery disease
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

AustraliaRamonl varcoeUniversity of new south walesSciencex networkWales hospitalNew south walesEluting resorbable scaffoldInfrapopliteal artery diseaseNew england journalDrug eluting resorbable scaffold